During the past nine years, the DERC, with its Core Laboratories, Enrichment Program and support for Pilot and Feasibility. studies, has played a major role in allowing for expansion in the scope and intensity of research at the Joslin Diabetes Center and Harvard Medical School. The DERC has provided essential support for interdisciplinary studies and junior faculty, and a critical infrastructure for both basic and clinical research. It is not surprising, therefore, that over his period there has been a further strengthening of the research effort at the Joslin, a significant increase in the publications in peer-reviewed journals and a more than 50% increase in training of research fellows. Recognizing this growth in research activity and the importance of the research mission, the Joslin added three floors to its building with over 30,000 sq. ft. of additional research space, and has renovated research space in the original building, all of which has resulted in improved laboratory space for individual investigators and the DERC Core Laboratories. In this renewal application, we have attempted to build on those strengths by eliminating Core Laboratories which were underutilized (such as Flow Cytometry) and adding new Cores (such as the Computer Resource Core). In addition, we have expanded the scope of the services provided by most Cores, but especially, the Peptide Biochemistry Core, the Microscopy Core, the Radioligand Assay Laboratory for the Clinical Research Core and the Transgenic Animal Core. At the last renewal we added one Pilot and Feasibility grant to our Center for use by scientists in the Longwood area outside the Joslin and affiliated with Harvard hospitals (e.g. Harvard Medical School, Children's Hospital, Beth Israel Hospital, Brigham and Women's Hospital, Deaconess Hospital, Dana Farber Cancer Institute, Center for Blood Research and Massachusetts General Hospital), and this program will continue. Within the DERC and the Joslin we have been particularly encouraged over the past four years by the development of younger faculty who have bean supported directly and indirectly by the DERC, such as Drs. Jackson, White, Hattori, Maratos-Flier, Rhodes, Shoelson, Lipes, Goodyear and others. These individuals, along with more established investigators and new faculty recruited by virtue of expansion, create the scientific base and strength of the Joslin DERC. Finally, the strong intellectual stimulus provided by the activities of the Enrichment Program have a major impact, not only at the Joslin, but in the whole Harvard-Longwood Medical area.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK036836-15
Application #
6329331
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (08))
Program Officer
Abraham, Kristin M
Project Start
1986-09-30
Project End
2002-03-31
Budget Start
2000-12-01
Budget End
2002-03-31
Support Year
15
Fiscal Year
2001
Total Cost
$1,248,750
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Shah, Hetal S; Morieri, Mario Luca; Marcovina, Santica M et al. (2018) Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD. Diabetes Care 41:348-355
Stanford, Kristin I; Lynes, Matthew D; Takahashi, Hirokazu et al. (2018) 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab 27:1357
Morieri, Mario Luca; Gao, He; Pigeyre, Marie et al. (2018) Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial. Diabetes Care 41:2404-2413
Mul, Joram D; Soto, Marion; Cahill, Michael E et al. (2018) Voluntary wheel running promotes resilience to chronic social defeat stress in mice: a role for nucleus accumbens ?FosB. Neuropsychopharmacology 43:1934-1942
Katz, Michelle L; Guo, Zijing; Cheema, Alina et al. (2018) Management of Cardiovascular Disease Risk in Teens with Type 1 Diabetes: Perspectives of Teens With and Without Dyslipidemia and Parents. Pediatr Diabetes :
Rezanejad, Habib; Ouziel-Yahalom, Limor; Keyzer, Charlotte A et al. (2018) Heterogeneity of SOX9 and HNF1? in Pancreatic Ducts Is Dynamic. Stem Cell Reports 10:725-738
Teló, G H; Dougher, C E; Volkening, L K et al. (2018) Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes. Diabet Med 35:1355-1363
Gordin, Daniel; Harjutsalo, Valma; Tinsley, Liane et al. (2018) Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 41:815-822
Goldford, Joshua E; Lu, Nanxi; Baji?, Djordje et al. (2018) Emergent simplicity in microbial community assembly. Science 361:469-474
Srinivasan, Shylaja; Kaur, Varinderpal; Chamarthi, Bindu et al. (2018) TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). Diabetes Care 41:554-561

Showing the most recent 10 out of 1120 publications